by Csequence | Jun 24, 2022 | Communications, Weekly Cannabis News
June 17th – June 24th, 2022 Cognitive Behavioral Therapy (CBT) to Stop Cannabis in First-Episode Psychosis (FEP) Patients Specific CBT treatments may be good interventional strategies to reduce cannabis use severity in FEB cannabis consumers, a new study suggests....by Csequence | Jun 17, 2022 | Communications, Weekly Cannabis News
June 10th – June 17th, 2022 Effects of Cannabis Exposure on DNA Methylation in Sperm Cells Findings may provide a better understanding on the consequences of paternal cannabis use on DNA. Cannabis is the most widely illicit drug consumed in the US, with increasing use...by Csequence | Jun 15, 2022 | Communications, Weekly Cannabis News
May 27th – June 3rd, 2022 Cannabinoid Receptor 1 Blockade: A Novel Therapeutic Target to Treat Lower Urinary Tract Symptoms (LUTSs)? Administration of a CB1R antagonist decreased LUTSs in a mouse model of induced bladder dysfunction, a new study suggests. The...by Csequence | Jun 14, 2022 | Communications, Weekly Cannabis News
May 20th – May 27th, 2022 Medical Cannabis Inhalers to Reduce Pain? Following medical cannabis inhalation, pain and opioid use were reduced while overall quality of life (QoL) was improved, a new study suggests. Medical cannabis has long been viewed as an alternative...by Csequence | Jun 13, 2022 | Communications, Weekly Cannabis News
May 13th -May 20th 2022 Medical Cannabis to Reduce Cancer-Associated Symptoms: Results from a Prospective Longitudinal Study Patients’ surveys indicated a decrease in total cancer symptoms burden during six months of medical cannabis treatment. Cancer development is...